Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0ND9T
|
||||
Former ID |
DNCL002537
|
||||
Drug Name |
CRLX101
|
||||
Indication | Late-stage solid tumors [ICD9: 140-199, 210-229; ICD10:C00-C75, C7A, C7B, D10-D36, D3A] | Phase 2 | [524225] | ||
Company |
Cerulean Pharma
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Toposisomerase-1 | Target Info | Modulator | ||
NetPath Pathway | IL2 Signaling Pathway | ||||
PANTHER Pathway | DNA replication | ||||
Pathway Interaction Database | Caspase Cascade in Apoptosis | ||||
WikiPathways | Integrated Pancreatic Cancer Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.